Gene Delivery Using Chemical Methods - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 184

[15] Kwoh DY, Coffin CC, Lollo CP, Jovenal J, Banaszczyk MG, Mullen P, et al. Stabilization
of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver. Biochim Biophys
Acta 1999;1444:171-90.
[16] Choi YH, Liu F, Kim JS, Choi YK, Park JS, Kim SW. Polyethylene glycol-grafted poly-
L-lysine as polymeric gene carrier. J Control Release 1998;54:39-48.
[17] Liu G, Molas M, Grossmann GA, Pasumarthy M, Perales JC, Cooper MJ, et al.
Biological properties of poly-L-lysine-DNA complexes generated by cooperative binding
of the poly cation. J Biol Chem 2001;276:34379-87.
[18] Perales JC, Grossmann GA, Molas M, Liu G, Ferkol T, Harpst J, et al. Biochemical and
functional characterization of DNA complexes capable of targeting genes to hepatocytes
via the asialoglycoprotein receptor. J Biol Chem 1997;272:7398-407.
[19] Pouton CW, Lucas P, Thomas BJ, Uduehi AN, Milroy DA, Moss SH. Polycation-DNA
complexes for gene delivery: a comparison of the biopharmaceutical properties of cat-
ionic polypeptides and cationic lipids. J Control Release 1998;53:289-99.
[20] Ward CM, Read ML, Seymour LW. Systemic circulation of poly(L-lysine)/DNA vectors
is influenced by polycation molecular weight and type of DNA: differential circulation in
mice and rats and the implications for human gene therapy. Blood 2001;97:2221-9.
[21] Katayose S, Kataoka K. Remarkable increase in nuclease resistance of plasmid DNA
through supramolecular assembly with poly(ethylene glycol)-poly(L-lysine) block copo-
lymer. J Pharm Sci 1998;87:160-3.
[22] Katayose S, Kataoka K. Water-soluble polyion complex associates of DNA and
poly(ethylene glycol)-poly(L-lysine) block copolymer. Bioconjug Chem 1997;8:702-7.
[23] Wolfert MA, Schacht EH, Toncheva V, Ulbrich K, Nazarova O, Seymour LW.
Characterization of vectors for gene therapy formed by self-assembly of DNA with syn-
thetic block co-polymers. Hum Gene Ther 1996;7:2123-33.
[24] Harada-Shiba M, Yamauchi K, Harada A, Takamisawa I, Shimokado K, Kataoka K.
Polyion complex micelles as vectors in gene therapy—pharmacokinetics and in vivo gene
transfer. Gene Ther 2002;9:407-14.
[25] Lee M, Han SO, Ko KS, Koh JJ, Park JS, Yoon JW, et al. Repression of GAD autoantigen
expression in pancreas beta-cells by delivery of antisense plasmid/PEG- g -PLL complex.
Mol Ther 2001;4:339-46.
[26] Trubetskoy VS, Torchilin VP, Kennel SL, Huang L. Use of N-terminal modified poly
(L-lysine)-antibody conjugated as a carrier for targeted gene delivery in mouse lung
endothelial cells. Bioconjug Chem 1992;3:323-7.
[27] Suh W, Chung JK, Park SH, Kim SW. Anti-JL1 antibody-conjugated poly (L-lysine) for
targeted gene delivery to leukemia T cells. J Control Release 2001;72:171-8.
[28] Lu Y, Low PS. FOL-mediated delivery of macromolecular anticancer therapeutic agents.
Adv Drug Delivery Rev 2002;54:675-93.
[29] Mislick KA, Baldeschwieler JD, Kayyem JF, Meade TJ. Transfection of FOL-
polylysine DNA complexes: evidence for lysosomal delivery. Bioconjugate Chem 1995;
6:512-15.
[30] Leamon CP, Low PS. Cytotoxicity of momordin-FOL conjugates in cultured human
cells. J Biol Chem 1992;267:24966-71.
[31] Ward CM, Pechar M, Oupicky D, Ulbrich K, Seymour LW. Modification of PLL-DNA
complexes with a multivalent hydrophilic polymer permits FOL-mediated targeting in
vitro and prolonged plasma circulation in vivo . J Gene Med 2002;4:536-47.
[32] Midoux P, Mendes C, Legrand A, Raimond J, Mayer R, Monsigny M, et al. Specific gene
transfer mediated by lactosylated poly-L-lysine into hepatoma cells. Nucleic Acids Res
1993;21:871-8.